Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF JUNE 12, 2022 SAM #7499
SOLICITATION NOTICE

66 -- Microfluid MFCS-EX System

Notice Date

6/10/2022 7:42:32 AM
 

Notice Type

Presolicitation
 

NAICS

334516 — Analytical Laboratory Instrument Manufacturing
 

Contracting Office

NATIONAL INSTITUTES OF HEALTH - CC BETHESDA MD 20892 USA
 

ZIP Code

20892
 

Solicitation Number

22-010630
 

Response Due

6/18/2022 7:00:00 AM
 

Archive Date

06/19/2023
 

Point of Contact

Priscilla Abalos
 

E-Mail Address

Priscilla.abalos@nih.gov
(Priscilla.abalos@nih.gov)
 

Description

Solicitation # HHSNIHOPCSBSS-22-010630 Date Posted ��June �10, 2022 Date�� closed� June� 18, 2022 This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health (NIH), Clinical Center (CC),Critical Care Medicine Department (CCMD) intends to solicit a quote and enter into firm-fixed price for Microfluid MFCS-EX System, with Fluigent Inc. Fluigent Inc is an international company which develops, manufactures It is an international company which develops, manufactures and supports the most advanced fluid control systems available for microfluidics. Whether your application is with droplets, cell biology, particle studies, or in other research areas, they have the expertise and knowledge to provide the most cost-effective and technically advanced solutions for� fluid control needs. This acquisition is being conducted using policies unique to the acquisition of commercial items prescribed in FAR Part 12, in conjunction with the policies and procedures for the competition requirements of Part 6. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date, February 18, 2022 at 10:00 EST specified in this announcement, electronically to the attention of Priscilla Abalos, Contract Specialist, Priscilla.abalos@nih.gov by the due date and time marked in this notice. Solicitation # HHSNIHOPCSBSS-22-010630 Date Posted ��June �10, 2022 Date�� closed� June� 18, 2022 This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health (NIH), Clinical Center (CC),Critical Care Medicine Department (CCMD) intends to solicit a quote and enter into firm-fixed price for Microfluid MFCS-EX System, with Fluigent Inc. Fluigent Inc is an international company which develops, manufactures It is an international company which develops, manufactures and supports the most advanced fluid control systems available for microfluidics. Whether your application is with droplets, cell biology, particle studies, or in other research areas, they have the expertise and knowledge to provide the most cost-effective and technically advanced solutions for� fluid control needs. This acquisition is being conducted using policies unique to the acquisition of commercial items prescribed in FAR Part 12, in conjunction with the policies and procedures for the competition requirements of Part 6. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date, February 18, 2022 at 10:00 EST specified in this announcement, electronically to the attention of Priscilla Abalos, Contract Specialist, Priscilla.abalos@nih.gov by the due date and time marked in this notice. Solicitation # HHSNIHOPCSBSS-22-010630 Date Posted ��June �10, 2022 Date�� closed� June� 18, 2022 This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health (NIH), Clinical Center (CC),Critical Care Medicine Department (CCMD) intends to solicit a quote and enter into firm-fixed price for Microfluid MFCS-EX System, with Fluigent Inc. Fluigent Inc is an international company which develops, manufactures It is an international company which develops, manufactures and supports the most advanced fluid control systems available for microfluidics. Whether your application is with droplets, cell biology, particle studies, or in other research areas, they have the expertise and knowledge to provide the most cost-effective and technically advanced solutions for� fluid control needs. This acquisition is being conducted using policies unique to the acquisition of commercial items prescribed in FAR Part 12, in conjunction with the policies and procedures for the competition requirements of Part 6. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date, February 18, 2022 at 10:00 EST specified in this announcement, electronically to the attention of Priscilla Abalos, Contract Specialist, Priscilla.abalos@nih.gov by the due date and time marked in this notice. Solicitation # HHSNIHOPCSBSS-22-010630 Date Posted ��June �10, 2022 Date�� closed� June� 18, 2022 This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health (NIH), Clinical Center (CC),Critical Care Medicine Department (CCMD) intends to solicit a quote and enter into firm-fixed price for Microfluid MFCS-EX System, with Fluigent Inc. Fluigent Inc is an international company which develops, manufactures It is an international company which develops, manufactures and supports the most advanced fluid control systems available for microfluidics. Whether your application is with droplets, cell biology, particle studies, or in other research areas, they have the expertise and knowledge to provide the most cost-effective and technically advanced solutions for� fluid control needs. This acquisition is being conducted using policies unique to the acquisition of commercial items prescribed in FAR Part 12, in conjunction with the policies and procedures for the competition requirements of Part 6. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date, February 18, 2022 at 10:00 EST specified in this announcement, electronically to the attention of Priscilla Abalos, Contract Specialist, Priscilla.abalos@nih.gov by the due date and time marked in this notice. Solicitation # HHSNIHOPCSBSS-22-010630 Date Posted ��June �10, 2022 Date�� closed� June� 18, 2022 This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health (NIH), Clinical Center (CC),Critical Care Medicine Department (CCMD) intends to solicit a quote and enter into firm-fixed price for Microfluid MFCS-EX System, with Fluigent Inc. Fluigent Inc is an international company which develops, manufactures It is an international company which develops, manufactures and supports the most advanced fluid control systems available for microfluidics. Whether your application is with droplets, cell biology, particle studies, or in other research areas, they have the expertise and knowledge to provide the most cost-effective and technically advanced solutions for� fluid control needs. This acquisition is being conducted using policies unique to the acquisition of commercial items prescribed in FAR Part 12, in conjunction with the policies and procedures for the competition requirements of Part 6. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date, February 18, 2022 at 10:00 EST specified in this announcement, electronically to the attention of Priscilla Abalos, Contract Specialist, Priscilla.abalos@nih.gov by the due date and time marked in this notice.
 

Web Link

SAM.gov Permalink
(https://sam.gov/opp/1566cff86d334462af1320ea4e3a7a5a/view)
 

Place of Performance

Address: Bethesda, MD 20892, USA

Zip Code: 20892

Country: USA
 

Record

SN06354968-F 20220612/220610230105 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |